Quadrant Capital Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $749K | Sell |
2,387
-972
| -29% | -$305K | 0.03% | 627 |
|
2025
Q1 | $1.02M | Buy |
3,359
+1,072
| +47% | +$327K | 0.04% | 376 |
|
2024
Q4 | $760K | Buy |
2,287
+93
| +4% | +$30.9K | 0.05% | 241 |
|
2024
Q3 | $732K | Sell |
2,194
-6
| -0.3% | -$2K | 0.05% | 262 |
|
2024
Q2 | $906K | Buy |
2,200
+1,739
| +377% | +$716K | 0.07% | 206 |
|
2024
Q1 | $186K | Hold |
461
| – | – | 0.01% | 666 |
|
2023
Q4 | $141K | Sell |
461
-4,135
| -90% | -$1.27M | 0.01% | 799 |
|
2023
Q3 | $1.11M | Buy |
4,596
+189
| +4% | +$45.8K | 0.11% | 134 |
|
2023
Q2 | $1.06M | Buy |
4,407
+2
| +0% | +$480 | 0.11% | 134 |
|
2023
Q1 | $828K | Buy |
4,405
+3,934
| +835% | +$740K | 0.09% | 169 |
|
2022
Q4 | $100K | Buy |
471
+88
| +23% | +$18.7K | 0.01% | 772 |
|
2022
Q3 | $60K | Buy |
383
+14
| +4% | +$2.19K | 0.01% | 940 |
|
2022
Q2 | $55K | Buy |
369
+69
| +23% | +$10.3K | 0.01% | 841 |
|
2022
Q1 | $49K | Buy |
300
+21
| +8% | +$3.43K | 0.01% | 930 |
|
2021
Q4 | $61K | Buy |
279
+47
| +20% | +$10.3K | 0.01% | 843 |
|
2021
Q3 | $44K | Buy |
232
+219
| +1,685% | +$41.5K | 0.01% | 919 |
|
2021
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 2118 |
|
2021
Q1 | $2K | Buy |
13
+9
| +225% | +$1.39K | ﹤0.01% | 2088 |
|
2020
Q4 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 2147 |
|
2020
Q2 | – | Sell |
-436
| Closed | -$32K | – | 2328 |
|
2020
Q1 | $32K | Hold |
436
| – | – | 0.01% | 1083 |
|
2019
Q4 | $36K | Hold |
436
| – | – | ﹤0.01% | 1485 |
|
2019
Q3 | $36K | Hold |
436
| – | – | 0.01% | 1360 |
|
2019
Q2 | $28K | Buy |
+436
| New | +$28K | ﹤0.01% | 1492 |
|